pyrazinamide has been researched along with Encephalopathy, Hepatic in 5 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A new, precise, and very selective method for increasing the impact and assessment of 3-nitrotyrosine (3-Nty) as a biomarker for early diagnosis of liver cirrhosis with minimal hepatic encephalopathy (MHE) disease was developed." | 7.83 | Nano optical sensor binuclear Pt-2-pyrazinecarboxylic acid -bipyridine for enhancement of the efficiency of 3-nitrotyrosine biomarker for early diagnosis of liver cirrhosis with minimal hepatic encephalopathy. ( Al-Radadi, NS; Attia, MS, 2016) |
| "A new, precise, and very selective method for increasing the impact and assessment of 3-nitrotyrosine (3-Nty) as a biomarker for early diagnosis of liver cirrhosis with minimal hepatic encephalopathy (MHE) disease was developed." | 3.83 | Nano optical sensor binuclear Pt-2-pyrazinecarboxylic acid -bipyridine for enhancement of the efficiency of 3-nitrotyrosine biomarker for early diagnosis of liver cirrhosis with minimal hepatic encephalopathy. ( Al-Radadi, NS; Attia, MS, 2016) |
| "Four patients presented hepatic encephalopathy." | 1.29 | [Severe hepatotoxicity of tuberculostatic agents. Increase in the incidence]. ( Bruguera, M; Mas, A; Moitinho, E; Rodés, J; Salmerón, JM, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attia, MS | 1 |
| Al-Radadi, NS | 1 |
| Durand, F | 2 |
| Bernuau, J | 2 |
| Pessayre, D | 2 |
| Samuel, D | 1 |
| Belaiche, J | 1 |
| Degott, C | 1 |
| Bismuth, H | 1 |
| Belghiti, J | 2 |
| Erlinger, S | 2 |
| Rueff, B | 1 |
| Fournier, M | 1 |
| Moitinho, E | 1 |
| Salmerón, JM | 1 |
| Mas, A | 1 |
| Bruguera, M | 1 |
| Rodés, J | 1 |
| Garavelli, PL | 1 |
1 review available for pyrazinamide and Encephalopathy, Hepatic
| Article | Year |
|---|---|
[Fulminant hepatitis during the therapy for tuberculous meningitis].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Female; Hepati | 1996 |
4 other studies available for pyrazinamide and Encephalopathy, Hepatic
| Article | Year |
|---|---|
Nano optical sensor binuclear Pt-2-pyrazinecarboxylic acid -bipyridine for enhancement of the efficiency of 3-nitrotyrosine biomarker for early diagnosis of liver cirrhosis with minimal hepatic encephalopathy.
Topics: Adult; Biomarkers; Early Diagnosis; Equipment Design; Equipment Failure Analysis; Female; Hepatic En | 2016 |
Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Hepatic Encephalopathy; Humans; Isoniazi | 1995 |
Antituberculous therapy and acute liver failure.
Topics: Antitubercular Agents; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Isoniazid; Liver F | 1995 |
[Severe hepatotoxicity of tuberculostatic agents. Increase in the incidence].
Topics: Acute Disease; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Chemical and Drug Induced | 1996 |